Loading clinical trials...
Loading clinical trials...
An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Major Depressive Disorder
Conditions
Interventions
AXS-05 (dextromethorphan and bupropion) oral tablets
Locations
51
United States
Clinical Research Site
Phoenix, Arizona, United States
Clinical Research Site
Little Rock, Arkansas, United States
Clinical Research Site
Bellflower, California, United States
Clinical Research Site
Beverly Hills, California, United States
Clinical Research Site
Culver City, California, United States
Clinical Research Site
Garden Grove, California, United States
Start Date
July 8, 2019
Primary Completion Date
October 23, 2020
Completion Date
October 23, 2020
Last Updated
October 12, 2022
NCT07073963
NCT05883540
NCT06790641
NCT06373718
NCT07538427
NCT07420205
Lead Sponsor
Axsome Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions